| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/29/2007 | US20070073041 Human tumor necrosis factor receptor polypeptides |
| 03/29/2007 | US20070073040 Anti-obesity polypeptides |
| 03/29/2007 | US20070073039 Peptides that inhibit viral infections |
| 03/29/2007 | US20070072979 Dispersing agents in nanocomposites |
| 03/29/2007 | US20070072903 Altering the concentration of intracellular agents by p2x7 receptor modulation |
| 03/29/2007 | US20070072818 Endothelial growth factors; antiischemic agents; neovascularization |
| 03/29/2007 | US20070072805 Fusion peptide-induced hemolysis effectively inhibited by peptides of the invention compared to virus-inhibitory peptide (VIRIP); peptide blocks cellular infection by HIV particles by interacting with the fusion peptide of HIV viral glycoprotein 41 (gp41) to prevent virus entry into thecell |
| 03/29/2007 | US20070072802 Peptide nucleic acid based guanidinium compounds |
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 03/29/2007 | US20070072799 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 03/29/2007 | US20070072797 Epitopes |
| 03/29/2007 | US20070072794 Novel genes and proteins encoded thereby |
| 03/29/2007 | US20070072791 Polypeptides biodrugs with given amino acid sequence which includes phosphorylated serine or threonine; Type II Diabetes and Alzheimer's Disease |
| 03/29/2007 | US20070072790 Antitumor agents |
| 03/29/2007 | US20070072296 C/EBPalpha gene targeting constructs and uses thereof |
| 03/29/2007 | US20070072282 Bovine adeno-associated viral (baav) vector and uses thereof |
| 03/29/2007 | US20070072273 use in host cells for biosynthesis of fine chemicals such as lysine; gene stability, gene expression or protein secretion/protein folding (SES proteins) |
| 03/29/2007 | US20070072271 Method for the production of recombinant proteins |
| 03/29/2007 | US20070072267 Transformant having galactose induction system and use thereof |
| 03/29/2007 | US20070072266 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof |
| 03/29/2007 | US20070072265 Expression vector comprising nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) proteins for enhancing production of functional heterologous polypeptides |
| 03/29/2007 | US20070072264 Recombinant chimeric acetylcholine receptors and their derivatives recognized by cd4 t cells of myasthenic patients for the treatment of myasthenia gravis |
| 03/29/2007 | US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog |
| 03/29/2007 | US20070072260 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 03/29/2007 | US20070072259 Fluorescent protein |
| 03/29/2007 | US20070072249 Human cytokine and alpha-helix-containing polypeptides |
| 03/29/2007 | US20070072245 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs |
| 03/29/2007 | US20070072239 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/29/2007 | US20070072238 Wnt-frizzled chimera |
| 03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
| 03/29/2007 | US20070072234 Protein capable of binding plasticizer |
| 03/29/2007 | US20070072231 Tumor suppressor gene |
| 03/29/2007 | US20070072230 tubulin; inhibitor of cell proliferation; for drug screening |
| 03/29/2007 | US20070072218 A polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO:1, sequence operably linked to a heterologous promoter selected from hsp68, SV40, CMV, GAL4UAS, HSV and beta -actin; anticarcinogenic agents |
| 03/29/2007 | US20070072217 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 03/29/2007 | US20070072202 toll-like receptors; lipoproteins |
| 03/29/2007 | US20070072192 Novel polypeptides encoded by essential bacterial genes |
| 03/29/2007 | US20070072191 Infectious pestivirus pseudo-particles containing functional erns, e1, e2 envelope proteins |
| 03/29/2007 | US20070072186 Methods and agents for screening for compounds capable of modulating her2 expression |
| 03/29/2007 | US20070072185 Carbohydrate-binding modules of a new family |
| 03/29/2007 | US20070072177 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections |
| 03/29/2007 | US20070072176 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 03/29/2007 | US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein |
| 03/29/2007 | US20070071775 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination |
| 03/29/2007 | US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae |
| 03/29/2007 | US20070071773 Compositions and methods for the treatment and prophylaxis of infections caused by gram positive bacteria |
| 03/29/2007 | US20070071770 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071769 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071767 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology |
| 03/29/2007 | US20070071766 Compositions comprising fungal immunomodulatory protein and use thereof |
| 03/29/2007 | US20070071750 Comprises heavy and light chain; treating envenomation by administering to neutralize in vivo effect |
| 03/29/2007 | US20070071743 Novel human cell surface protein with immunoglobulin folds, BGS-19 |
| 03/29/2007 | US20070071741 OCL-2A3 compositions and uses thereof |
| 03/29/2007 | US20070071726 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 03/29/2007 | US20070071721 Methods for treating viral infection using il-28 and il-29 |
| 03/29/2007 | US20070071719 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 03/29/2007 | US20070071714 Stem cell factor |
| 03/29/2007 | US20070071677 Non-toxic membrane-translocating peptides |
| 03/29/2007 | US20070071674 Polynucleotides encoding novel isoforms of IGSF9 |
| 03/29/2007 | DE102005046113A1 Preparation of C-amidated peptides, useful as pharmaceuticals, by reaction between precursor peptides in presence of enzyme with activity of trypsin, also new reaction products |
| 03/29/2007 | CA2664549A1 Library from toxin mutants, and methods of using same |
| 03/29/2007 | CA2623424A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 03/29/2007 | CA2623176A1 Protein a production and purification without using animal derived components |
| 03/29/2007 | CA2622687A1 Methods for genetic control of insect infestations in plants and compositions thereof |
| 03/29/2007 | CA2622542A1 Protein a production and purification without using animal derived components |
| 03/29/2007 | CA2622436A1 Acaricidal compositions and methods of use thereof |
| 03/29/2007 | CA2621328A1 Gene encoding cell wall mannoprotein and use thereof |
| 03/28/2007 | EP1767945A1 Phosphorylated or non-phosphorylated mPR as diagnostic marker or therapeutic target |
| 03/28/2007 | EP1767944A1 Phosphorylated or non-phosphorylated mPR as diagnostic marker or therapeutic target |
| 03/28/2007 | EP1767655A1 Method of controlling cell functions |
| 03/28/2007 | EP1767653A1 Probe for diagnosis of marfan's syndrome and method of screening with the probe |
| 03/28/2007 | EP1767646A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same |
| 03/28/2007 | EP1767643A1 Host cells and methods for the cytoprotection from oxidative and nitrosative stress |
| 03/28/2007 | EP1767641A1 Antigenic neisserial peptides |
| 03/28/2007 | EP1767639A1 Oral vaccine against protozoiasis using genetically modified plant |
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
| 03/28/2007 | EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 03/28/2007 | EP1767635A1 Fluorescent protein |
| 03/28/2007 | EP1767634A1 Novel galectin 8 modification protein and use thereof |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767625A1 Activity regulator for interferon producing cell |
| 03/28/2007 | EP1767546A1 Angiogenesis-inhibiting chimeric protein and the use |
| 03/28/2007 | EP1767545A1 GLP-1 (Glucagon-like peptide-1) fusion polypeptides with increased peptidase resistance |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767543A1 Novel bee venom polypeptides and methods of use thereof |
| 03/28/2007 | EP1767542A2 HLA-A2. 1 binding peptides and their uses |
| 03/28/2007 | EP1767541A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein |
| 03/28/2007 | EP1766768A2 Use of lacritin in promoting ocular cell survival |
| 03/28/2007 | EP1766411A2 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 03/28/2007 | EP1766390A2 Novel means and methods for the treatment of hearing loss and phantom hearing |
| 03/28/2007 | EP1766388A2 Stable isotope labeled polypeptide standards for protein quantitation |
| 03/28/2007 | EP1766096A2 Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectors |
| 03/28/2007 | EP1766082A2 Cog47 protein and s100beta gene polymorphism |
| 03/28/2007 | EP1766059A2 Influenza hemagglutinin and neuraminidase variants |
| 03/28/2007 | EP1766058A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 03/28/2007 | EP1766039A2 Methods of making nanotechnological and macromolecular biomimetic structures |
| 03/28/2007 | EP1766027A1 Fluorescent protein |
| 03/28/2007 | EP1766021A1 Polynucleotides for the detection of escherichia coli 157:h7 and escherichia coli 0157:nm verotoxin producers |
| 03/28/2007 | EP1766020A1 Polynucleotides for the detection of staphylococcus aureus |